Glucose-lowering effect of dioxopiperazinecarbonylphenylsulfonylcyclohexyl urea

LU Xiao-hua,Li Wei,ZHANG Gen-bao,GUI Chang-qing,WANG Guo-guang
DOI: https://doi.org/10.3969/j.issn.1002-0217.2009.03.004
2009-01-01
Abstract:Objective:To explore the effects of 1-(4-[2-(1-ethyl-2,3-dioxopiperazine-4-carboxamido)ethyl]-phenylsulfonyl)-3-cyclohexyl urea on the fasting blood glucose and the blood lipemia in the streptozotocin(STZ)-induced diabetic mice and the glucose uptake in SMMC7721 cells.Methods:The animal models of Type 2 diabetes were prepared by nourishment of high calorie and high fat and by injection of STZ.The enzyme colorimetry was used to detect the level of fasting blood glucose,triglyceride(TG),cholesterol(CHO)and scintillation was employed to examine the glucose uptake in SMM7721 cells.Results:The drug effectively decreased the blood glucose and improved the metabolism of blood lipemia in the STZ-induced mice.Compared with the control cells,the drug significantly improved the glucose uptake in SMMC7721 cells(P<0.01)and the uptake of 2-deoxy-[3H] glucose in SMMC7721 cells increased by twice,with evident insulin-stimulated glucose uptake(P<0.01).Conclusion:The new drug could modify the blood glucose and lipemia in STZ-induced mice and improve the glucose uptake in SMMC7721 cells,and it may be a potential anti-hyperglycemic agent.
What problem does this paper attempt to address?